New long-acting muscarinic antagonist-long-acting beta agonist users had a decreased risk for a first moderate/severe COPD exacerbation with a dry powder inhaler vs. a metered-dose or soft mist ...

Zydus Lifesciences Limited, an innovation-led life-sciences company with an international presence, has launched Aerolife ...

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.

Arizona's health agency recalled 'Cheech and Chong' apple fritter prerolls due to mold, posing lung risks to consumers.

Cigarettes are reappearing across pop culture as a symbol of cool rather than controversy. Experts say this aesthetic shift reflects a move away from “clean” wellness culture, even as actual smoking ...

The Philadelphia hospital treats complex cases and expands access to transplant care for patients who may not qualify ...

For many years, people didn’t know a lot about what was in the products they used. Today, people hold manufacturers more accountable than ever, and you can easily access information about every ...

A new study published in the Journal of the American Medical Association found that among patients at increased risk of ...

Ralinepag reduced the risk of clinical worsening in patients with pulmonary arterial hypertension by 55%, according to recent study results.

When Gossamer Bio announced poor results from its flagship blood pressure study in February, the San Diego company’s stock dropped by 78% in value. Now, it’s slashing its staff. The biotech lab began ...